Cite
HARVARD Citation
Takashi, U. et al. (n.d.). 2301 Phase 2 study of Nivolumab (Anti-PD-1; ONO-4538) in Patients with Esophageal Cancer: Preliminary Report. European journal of cancer. pp. S432-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Takashi, U. et al. (n.d.). 2301 Phase 2 study of Nivolumab (Anti-PD-1; ONO-4538) in Patients with Esophageal Cancer: Preliminary Report. European journal of cancer. pp. S432-. [Online].